| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.9M | +52.2% |
| SG&A Expense | $2.2M | -19.1% |
| Operating Income | -$4.2M | -3.9% |
| Pre-tax Income | -$5.2M | +5.6% |
| Net Income | -$5.2M | +5.6% |
| EPS (Basic) | -$0.18 | +5.3% |
| EPS (Diluted) | -$0.18 | +5.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $223K | +139.2% |
| Total Assets | $410K | +30.6% |
| Total Liabilities | $13.0M | +28.6% |
| Stockholders' Equity | -$12.6M | -28.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.1M | +7.1% |
| Financing Cash Flow | $3.3M | +1.3% |